Cargando…

S80. Prolongation of T cell response by OX40 co-signalling CARS

Detalles Bibliográficos
Autor principal:	Abken, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072132/ http://dx.doi.org/10.1186/2051-1426-2-S2-I18

Ejemplares similares

S79. CAR strategies in solid tumours
por: Rossig, C
Publicado: (2014)

Ethylene signaling via Ethylene Response Factors (ERFs) modifies wood development in hybrid aspen
por: Felten, Judith, et al.
Publicado: (2011)

S77. Proffered paper: In vitro induced response patterns of antileukemic T-cells – characterization by combination of functional assays, spectratyping and next generation sequencing
por: Reuther, S, et al.
Publicado: (2014)

Managing antiretrovirals in co-infected patients in 2012
por: Rockstroh, Jürgen
Publicado: (2012)

Capture in the metabolic arena: co-selection of gamma and deltaretrovirus envelope glycoproteins and their receptors
por: Sitbon, Marc, et al.
Publicado: (2009)

The acute response of tendon to loading: implications for rehabilitation
por: Wearing, Scott C, et al.
Publicado: (2011)

S50. Proffered paper: Complex tumour microenvironment screening platform captures biological responses of cancer therapeutics
por: Layman, H, et al.
Publicado: (2014)

Use of new resistance markers to predict virologic response to antiretrovirals
por: Wainberg, Mark A, et al.
Publicado: (2010)

Effects of glyceryl trinitrate and calcitonin-gene-related peptide on BOLD signal and arterial diameter –methodological studies by fMRI and MRA
por: Asghar, MS, et al.
Publicado: (2013)

S38. Many reasons for combining immunotherapy with chemotherapy to enhance anti tumour response
por: Dalgleish, A, et al.
Publicado: (2014)

PReS13-SPK-1350: Autoimmune responses following vaccination in healthy populations
por: Toplak, N
Publicado: (2013)

Streamlining regulation of clinical trials – update on the Academy of Medical Sciences review and government’s response
por: Ford, Gary A
Publicado: (2011)

Immunological and virological aspects of HIV cell-to-cell transfer
por: Schwartz, Olivier
Publicado: (2009)

The role of cytotoxic T cells
por: Sáez-Cirión, Asier
Publicado: (2010)

I-21 Current therapeutic guidelines in Duchenne Muscular Dystrophy to prolong life
por: Riccio, V., et al.
Publicado: (2011)

Role of human innate lymphoid cells in IMID
por: Spits, Hergen, et al.
Publicado: (2012)

NK Cells and immune activation in HIV-1 infection
por: Goodier, Martin R
Publicado: (2010)

Role of regulatory T cells in the pathogenesis of HIV-1 infection
por: Lévy, Yves
Publicado: (2009)

S43. Dendritic cell vaccination combined with CTLA4 blockade
por: Thielemans, K, et al.
Publicado: (2014)

S7. KEYNOTE LECTURE: Immunobiological properties of the human cancer stem cells
por: Maccalli, C, et al.
Publicado: (2014)

S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
por: Svane, I, et al.
Publicado: (2014)

Type 1 regulatory T (Tr1) cells: from the bench to the bedside
por: Gregori, Silvia, et al.
Publicado: (2012)

S82. Proffered paper: In-vivo testing of PSMA-targeted T-cell immunotherapy for prostate cancer
por: Liu, Z, et al.
Publicado: (2014)

OX40:OX40L axis: emerging targets for improving poxvirus‐based CD8(+) T‐cell vaccines against respiratory viruses
por: Goulding, John, et al.
Publicado: (2011)

S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy
por: Grassmann, S, et al.
Publicado: (2014)

PReS13-SPK-1292: Gut microbiome and metabolism
por: Tilg, H
Publicado: (2013)

PReS13-SPK-1028: Activity and damage - we have to measure them
por: Brunner, H
Publicado: (2013)

Dermatologic aspects of ectodermal dysplasias
por: Itin, Peter H
Publicado: (2012)

Transgenic biotechnology in forestry: what a long strange trip it's been
por: Strauss, Steven H
Publicado: (2011)

S5. Proffered paper: Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703: clinical and immunological predictive pretreatment factors of activity in the IMPACT trial
por: Schmoll, H, et al.
Publicado: (2014)

Skin microbiome in health and disease
por: Segre, Julie A, et al.
Publicado: (2010)

Origin of the human malaria parasite Plasmodium falciparum in gorillas
por: Liu, Weimin, et al.
Publicado: (2010)

Novel vaccine and gene therapy approaches against HIV-AIDS
por: Das, A, et al.
Publicado: (2009)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

INSP-08. Cerebellar mutism syndrome: incidence, symptoms, risk factors, prognosis. Results and future perspectives from the Nordic-European study of the cerebellar mutism syndrome
por: Sehested, Astrid, et al.
Publicado: (2022)

INSP-03. Neuronal regulation of glioma progression
por: Monje, Michelle
Publicado: (2022)

INSP-17. Augmented Drug Delivery for Pediatric Diffuse Midline Glioma using Convection Enhanced Delivery
por: Souweidane, Mark M
Publicado: (2022)

INSP-14. Novel approaches to molecular diagnostics
por: Sahm, Felix
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t9bdf1puaufurcj1q860qntl76